Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
524218 RESONANCE

Resonance Specialties Share Price

 

 

Resonance Specialties live price: ₹101.98. It opened at ₹98 vs previous close ₹98; intraday high/low: ₹102/₹96. The 50 & 200 DMA stand at ₹93.90/₹97.83.

Resonance Specialties Performance

  • Today's Low
  • ₹96
  • Today's High
  • ₹102
  • 52 Week Low
  • ₹69
  • 52 Week High
  • ₹125
  • Open Price₹98
  • Previous Close₹98
  • Volume7,074
  • 50 DMA₹93.90
  • 100 DMA₹96.25
  • 200 DMA₹97.83

Resonance Specialties Chart

Investment Returns

  • Over 1 Month + 11.93%
  • Over 3 Month + 2.96%
  • Over 6 Month + 8.67%
  • Over 1 Year + 29.68%

Smart Investing Starts Here Start SIP with Resonance Specialties for Steady Growth!

Invest Now

Resonance Specialties Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 13.3
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 118
  • P/B Ratio
  • 1.7
  • Average True Range
  • 5.8
  • EPS
  • -
  • Dividend Yield
  • 1
  • MACD Signal
  • -1.6
  • RSI
  • 64.41
  • MFI
  • 59

Resonance Specialties Financials

Resonance Specialties Technicals

EMA & SMA

Current Price
₹101.98
+ 4.13 (4.22%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹91.67
  • 50 Day
  • ₹93.90
  • 100 Day
  • ₹96.25
  • 200 Day
  • ₹97.83

Resistance and Support

99.84 Pivot Speed
  • R3 109.38
  • R2 105.68
  • R1 103.54
  • S1 97.70
  • S2 94.00
  • S3 91.86

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Resonance Specialities has an operating revenue of Rs. 89.97 Cr. on a trailing 12-month basis. An annual revenue growth of 40% is outstanding, Pre-tax margin of 11% is healthy, ROE of 10% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 46 which is a POOR score indicating inconsistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at C which is evident from recent supply seen, Group Rank of 90 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Resonance Specialties Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-04 Quarterly Results
2025-11-03 Quarterly Results
2025-08-05 Quarterly Results
2025-05-19 Audited Results & Final Dividend
2025-01-24 Quarterly Results
Date Purpose Remarks
2025-07-29 FINAL Rs.1.00 per share(10%)Final Dividend
2022-08-05 FINAL Rs.1.00 per share(10%)Dividend
2021-08-20 FINAL Rs.1.00 per share(10%)Final Dividend
View Resonance Specialties Dividend History Arrow

Resonance Specialties F&O

Resonance Specialties Shareholding Pattern

54.25%
35.29%
10.46%

Resonance Specialties FAQs

Resonance Specialties share price is ₹101 As on 16 April, 2026 | 20:19

The Market Cap of Resonance Specialties is ₹117.7 Cr As on 16 April, 2026 | 20:19

The P/E ratio of Resonance Specialties is 13.3 As on 16 April, 2026 | 20:19

The PB ratio of Resonance Specialties is 1.7 As on 16 April, 2026 | 20:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23